Best Diagnostic & Research Stocks to Buy Now (2024)Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.
Industry: Diagnostics & Research
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICLR | ICON PLC | $26.02B | $8.23B | $1.62B | $683.12M | $8.30 | 5.29% | 25.44% | 32.80% | 6.18% | ||
| STRR | STAR EQUITY HOLDINGS INC | $13.95M | $45.79M | $26.87M | $23.22M | $1.61 | -19.88% | -15.16% | N/A | 34.19% | 2024-05-20 | |
| FONR | FONAR CORP | $102.27M | $102.72M | $25.65M | $10.29M | $1.61 | 5.16% | 3.68% | 8.78% | -12.00% | 2024-05-20 | |
| TMO | THERMO FISHER SCIENTIFIC INC | $227.24B | $42.49B | $11.37B | $6.03B | $15.65 | -3.00% | 11.52% | 1.36% | 14.62% | 2024-05-22 | |
| IDXX | IDEXX LABORATORIES INC | $44.88B | $3.72B | $1.24B | $866.57M | $10.43 | 8.57% | 10.59% | 24.17% | 18.31% | ||
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | $11.42B | $4.11B | $1.00B | $438.82M | $8.55 | 0.49% | 11.59% | -12.40% | 12.47% | ||
| ENZ | ENZO BIOCHEM INC | $55.84M | $12.81M | $33.74M | $32.57M | $0.67 | N/A | -32.08% | N/A | N/A | 2024-06-12 | |
| DGX | QUEST DIAGNOSTICS INC | $16.03B | $9.29B | $1.70B | $846.00M | $7.53 | -3.29% | 4.26% | 8.66% | 7.24% | 2024-05-29 | |
| MEDP | MEDPACE HOLDINGS INC | $12.19B | $1.96B | $405.89M | $312.51M | $10.17 | 25.57% | 21.47% | 24.33% | 36.07% | ||
| SHC | SOTERA HEALTH CO | $3.20B | $1.08B | $426.24M | $54.86M | $0.19 | 9.05% | N/A | N/A | N/A | 2024-05-23 | |
| NEOG | NEOGEN CORP | $2.93B | $929.24M | $188.76M | $1.57M | $0.02 | 28.93% | 17.63% | -50.00% | -49.27% | ||
| LAB | STANDARD BIOTOOLS INC | $956.40M | $126.76M | -$76.45M | -$135.98M | -$1.01 | 31.27% | 1.47% | N/A | N/A | ||
| A | AGILENT TECHNOLOGIES INC | $45.20B | $6.74B | $1.69B | $1.24B | $4.22 | -2.81% | 6.19% | -5.17% | 3.46% | 2024-05-29 | |
| QGEN | QIAGEN NV | $10.23B | $1.94B | $680.17M | $336.94M | $1.47 | -2.99% | 5.17% | -3.36% | 10.88% | 2024-06-17 | |
| DHR | DANAHER CORP | $196.87B | $22.52B | $7.54B | $4.40B | $5.96 | -9.58% | 6.32% | -36.66% | 11.68% | ||
| FLGT | FULGENT GENETICS INC | $661.63M | $287.53M | -$127.63M | -$165.95M | -$5.57 | -21.20% | 67.10% | N/A | N/A | ||
| SERA | SERA PROGNOSTICS INC | $269.72M | $206.00k | -$32.31M | -$33.77M | -$1.07 | -37.58% | N/A | N/A | N/A | ||
| CSTL | CASTLE BIOSCIENCES INC | $669.20M | $250.73M | -$17.87M | -$30.80M | -$1.14 | 64.71% | 55.20% | N/A | N/A | ||
| EXAS | EXACT SCIENCES CORP | $9.30B | $2.53B | $32.77M | -$240.23M | -$1.32 | 15.21% | 36.95% | N/A | N/A | ||
| NTRA | NATERA INC | $13.07B | $1.21B | -$311.83M | -$365.46M | -$3.12 | 39.26% | 35.75% | N/A | N/A | ||
| PRE | PRENETICS GLOBAL LTD | $70.84M | $21.74M | -$55.20M | -$62.72M | -$5.58 | 65.17% | 18.68% | N/A | N/A | ||
| RVTY | REVVITY INC | $13.60B | $2.73B | $665.40M | $149.63M | $1.22 | -9.85% | -0.41% | -83.99% | -11.36% | ||
| CHEK | CHECK-CAP LTD | $12.78M | $0.00 | -$19.08M | -$17.57M | -$3.00 | N/A | N/A | N/A | N/A | ||
| OLK | OLINK HOLDING AB (PUBL) | $2.98B | $170.89M | -$21.35M | -$33.71M | -$0.27 | 18.16% | N/A | N/A | N/A | ||
| LH | LABCORP HOLDINGS INC | $17.75B | $12.30B | $1.55B | $433.10M | $5.10 | 4.62% | 1.75% | -54.34% | -10.52% | ||
| WAT | WATERS CORP | $21.11B | $2.91B | $979.13M | $603.51M | $10.21 | -1.94% | 3.89% | -11.60% | 5.51% | 2024-05-23 | |
| PRPO | PRECIPIO INC | $9.24M | $15.81M | -$3.37M | -$4.90M | -$3.42 | 61.64% | 40.73% | N/A | N/A | 2024-06-13 | |
| DRIO | DARIOHEALTH CORP | $56.85M | $19.04M | -$50.61M | -$59.90M | -$1.68 | -28.58% | 19.30% | N/A | N/A | ||
| NEO | NEOGENOMICS INC | $1.89B | $610.66M | $1.33M | -$84.23M | -$0.66 | 15.27% | 14.60% | N/A | N/A | 2024-05-23 | |
| TWST | TWIST BIOSCIENCE CORP | $2.74B | $277.49M | -$155.32M | -$192.14M | -$3.36 | 21.79% | 47.31% | N/A | N/A | ||
| IQV | IQVIA HOLDINGS INC | $42.12B | $15.07B | $3.27B | $1.36B | $7.42 | 3.97% | 7.43% | 30.86% | 43.25% | ||
| MTD | METTLER TOLEDO INTERNATIONAL INC | $32.52B | $3.79B | $1.17B | $777.86M | $35.85 | -4.18% | 5.08% | -9.65% | 11.11% | ||
| BNR | BURNING ROCK BIOTECH LTD | $85.03M | $74.33M | -$71.63M | -$90.41M | -$8.82 | -6.20% | 20.19% | N/A | N/A | 2024-05-28 | |
| ACRS | ACLARIS THERAPEUTICS INC | $84.81M | $31.12M | -$76.72M | -$77.26M | -$1.09 | 0.95% | 31.78% | N/A | N/A | 2024-06-06 | |
| RDNT | RADNET INC | $4.24B | $1.66B | $281.33M | $21.27M | $0.33 | 12.10% | 10.30% | N/A | -14.91% | ||
| CDNA | CAREDX INC | $807.30M | $275.11M | -$175.06M | -$183.19M | -$3.41 | -13.93% | 25.46% | N/A | N/A | ||
| PSNL | PERSONALIS INC | $72.71M | $74.15M | -$79.45M | -$92.61M | -$1.90 | 7.96% | 9.23% | N/A | N/A | ||
| STIM | NEURONETICS INC | $78.29M | $73.23M | -$19.49M | -$27.54M | -$0.95 | 10.01% | 5.76% | N/A | N/A | ||
| ME | 23ANDME HOLDING CO | $283.47M | $247.99M | -$490.64M | -$521.97M | -$1.11 | -19.40% | N/A | N/A | N/A | 2024-05-26 | |
| GH | GUARDANT HEALTH INC | $3.10B | $603.73M | -$414.22M | -$460.90M | -$3.96 | 25.21% | 40.42% | N/A | N/A | 2024-05-29 | |
| XWEL | XWELL INC | $7.28M | $31.77M | -$21.66M | -$24.74M | -$5.95 | -18.44% | -8.57% | N/A | N/A | ||
| OCX | ONCOCYTE CORP | $39.16M | $1.38M | -$38.55M | -$40.86M | -$5.08 | 57.94% | N/A | N/A | N/A | 2024-06-28 | |
| MYGN | MYRIAD GENETICS INC | $2.29B | $774.20M | -$163.70M | -$234.60M | -$2.80 | 11.44% | -1.37% | N/A | N/A | ||
| DMTK | DERMTECH INC | $17.45M | $15.66M | -$84.05M | -$89.63M | -$2.68 | 9.71% | 53.04% | N/A | N/A | 2024-05-30 | |
| XGN | EXAGEN INC | $32.66M | $55.73M | -$14.09M | -$19.36M | -$1.09 | 20.12% | N/A | N/A | N/A | 2024-06-10 | |
| PRPH | PROPHASE LABS INC | $95.97M | $28.72M | -$23.50M | -$23.60M | -$1.36 | -69.59% | 18.99% | N/A | N/A | ||
| AWH | ASPIRA WOMEN's HEALTH INC | $33.12M | $8.99M | -$14.60M | -$14.74M | -$1.42 | 4.46% | 22.90% | N/A | N/A | ||
| NDRA | ENDRA LIFE SCIENCES INC | $3.39M | $0.00 | -$9.63M | -$9.89M | -$1.14 | N/A | N/A | N/A | N/A | 2024-07-05 | |
| VNRX | VOLITIONRX LTD | $63.77M | $797.03k | -$33.26M | -$34.91M | -$0.46 | 133.06% | N/A | N/A | N/A | 2024-07-02 | |
| MDXH | MDXHEALTH SA | $7.86M | $75.33M | -$21.40M | -$39.90M | -$13.70 | 65.02% | N/A | N/A | N/A | 2024-06-05 | |
| GENE | GENETIC TECHNOLOGIES LTD | $526.30k | $5.55M | N/A | -$8.33M | -$2.98 | -3.27% | 136.93% | N/A | N/A | ||
| NOTV | INOTIV INC | $50.12M | $552.74M | $19.33M | -$71.29M | -$2.77 | -7.47% | 75.72% | N/A | N/A | ||
| BIAF | BIOAFFINITY TECHNOLOGIES INC | $26.35M | $4.94M | -$7.92M | -$8.37M | -$0.92 | 86,182.88% | N/A | N/A | N/A | ||
| MYNZ | MAINZ BIOMED NV | $14.39M | $895.48k | -$24.62M | -$26.30M | -$1.62 | 69.00% | N/A | N/A | N/A | 2024-05-31 | |
| ILMN | ILLUMINA INC | $17.69B | $4.49B | -$640.00M | -$1.29B | -$8.15 | 1.03% | 5.76% | N/A | N/A | ||
| OPK | OPKO HEALTH INC | $920.03M | $799.60M | -$128.11M | -$252.43M | -$0.35 | -12.38% | -3.55% | N/A | N/A | ||
| PMD | PSYCHEMEDICS CORP | $14.98M | $21.60M | -$970.00k | -$4.46M | -$0.77 | -12.18% | -12.27% | N/A | N/A | ||
| APDN | APPLIED DNA SCIENCES INC | $2.47M | $5.52M | -$11.10M | -$12.50M | -$17.31 | -68.52% | 7.33% | N/A | N/A | 2024-06-12 | |
| TRIB | TRINITY BIOTECH PLC | $12.11M | $56.83M | -$11.25M | -$24.02M | -$3.20 | -9.10% | -10.15% | N/A | N/A | ||
| BDSX | BIODESIX INC | $180.63M | $54.85M | -$32.10M | -$47.06M | -$0.54 | 34.70% | N/A | N/A | N/A | ||
| MMA | ALTA GLOBAL GROUP LTD | N/A | $1.54M | -$16.12M | -$20.60M | -$5.26 | 63.35% | N/A | N/A | N/A | ||
| ISPC | ISPECIMEN INC | $2.40M | $9.27M | -$9.41M | -$11.57M | -$1.28 | -14.45% | N/A | N/A | N/A | 2024-05-22 | |
| TTOO | T2 BIOSYSTEMS INC | $49.59M | $7.18M | -$38.59M | -$45.65M | -$11.51 | -58.15% | -6.37% | N/A | N/A | ||
| CNTG | CENTOGENE NV | $10.21M | $52.19M | -$20.95M | -$38.50M | -$1.37 | 6.78% | 3.00% | N/A | N/A | 2024-06-28 |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.